|1.||Pastan, Ira: 6 articles (05/2015 - 11/2002)|
|2.||Hassan, Raffit: 6 articles (05/2015 - 11/2002)|
|3.||Wilson, Ian A: 5 articles (03/2015 - 07/2011)|
|4.||Walzer, Peter D: 5 articles (07/2011 - 01/2003)|
|5.||Harris, David A: 5 articles (04/2010 - 07/2004)|
|6.||Mansfield, John M: 5 articles (09/2009 - 08/2003)|
|7.||Berndt, M C: 5 articles (08/2001 - 01/2000)|
|8.||Andrews, R K: 5 articles (08/2001 - 01/2000)|
|9.||Magez, Stefan: 4 articles (01/2015 - 05/2006)|
|10.||De Baetselier, Patrick: 4 articles (11/2014 - 05/2006)|
08/01/1993 - "The GP46/M-2 membrane glycoprotein has been demonstrated in a murine model system to elicit a protective immune response against infection with Leishmania amazonensis; in highly susceptible BALB/c mice, immunization leads to significant protection against infection. "
07/01/1993 - "These findings suggest that variant surface glycoprotein (VSG)-specific antibody activity and immunosuppression are effective in the skin and influence the outcome of infection with T. "
11/01/1990 - "Immunization of mice with the GP46/M-2 membrane glycoprotein has been demonstrated to elicit protection against infection with the parasitic protozoan Leishmania amazonensis. "
02/01/2013 - "In order to pinpoint the driving forces during infection, it is necessary to study the adhesive properties of human cell surface glycoproteins with regard to their primary amino acid sequence and post-translational modifications. "
01/01/2007 - "This paper describes many of the zoite surface glycoproteins potentially involved in infection, as well as summarizes many of the immunotherapeutic studies completed to date. "
|2.||Human Influenza (Influenza)
10/01/1998 - "These results indicate that both HA- and NA-expressing DNAs for the surface glycoproteins are most protective against influenza from among the various viral protein-expressing DNAs used here."
11/01/2013 - "In conclusion, it is suggested that the anti-influenza viral efficacy of EGCG is attributable to damage to the physical properties of the viral envelope and partial inhibition of the NA surface glycoprotein. "
09/01/1987 - "To study the genetic basis of this attenuation, we isolated influenza A/Pintail/79 X A/Washington/897/80 reassortant viruses which contained human influenza virus H3N2 surface glycoprotein genes and various combinations of avian or human influenza virus internal genes. "
09/03/2014 - "LAIVs are based on cold adapted and temperature sensitive phenotypes of master donor viruses (MDVs) containing the surface glycoprotein genes of seasonal influenza strains. "
01/01/2013 - "The hallmark of influenza virus is the remarkable variability of its major surface glycoproteins, HA and NA, which allows the virus to evade existing anti-influenza immunity in the target population. "
06/20/2015 - "The cell surface glycoprotein CD44 is expressed in cancer cells and has been used as a therapeutic target in preclinical studies. "
07/01/2008 - "The aim of this study was to determine the glycosylation patterns of surface glycoproteins of two cell lines C and D of ZAH by lectin binding for identification and characterization of tumor-specific markers. "
01/01/1991 - "Our studies suggest that these cell-surface glycoprotein alterations play a role in determining the malignant properties of the cells, and indicate that metastatic variants with the properties described in this report would be useful biological tools for investigations into the roles played by specific cell-surface structures in mechanisms of tumor progression."
05/01/1987 - "The human lung tumor used in the study expresses an Mr 160,000 cell surface glycoprotein that has been shown to occur on a large proportion of human lung tumors and tumor cell lines. "
07/01/1986 - "Results of this study indicated that the membrane glycoprotein with F-epitope may play a role in lodgement of the tumor cells in vitro and serve as an in vivo target of specific immune effectors."
12/01/1986 - "The importance of temperature control for development was illustrated by the response of variant surface glycoprotein-encoding genes to heat shock."
02/01/1992 - "The improved viability was associated with a significantly lower glycolytic rate; better maintenance of other in vitro parameters including respiratory activity, adenosine triphosphate levels, hypotonic shock response, surface glycoprotein Ib (by flow cytometry); and improved preservation of morphologic integrity (p less than 0.05). "
01/01/1991 - "Factorial analysis showed that a reduction in the surface-to-volume ratio of the storage container further improved the maintenance of platelet respiration and, for three in vitro markers (hypotonic shock response, released lactic dehydrogenase, and surface glycoprotein Ib levels) displayed an interactive effect with the inhibitors. "
07/01/1986 - "These studies establish this phosphorylated membrane glycoprotein as a member of the heat shock/stress protein family, and they add collagen binding to the unexpectedly diverse spectrum of biochemical activities induced by exposure of cells to stress."
04/01/1982 - "The results suggest that the Mr 90,000 cell surface glycoprotein and the Mr 70,000 and 72,000 heat shock-inducible proteins mediate an association between the plasma membrane and the cell cytoskeleton."
|5.||Melanoma (Melanoma, Malignant)
01/01/2015 - "Our study unravels the molecular alterations of cell-surface glycoprotein CD44 variants during melanoma progression to MBM. "
10/01/2002 - "Mel-CAM was first described as an integral membrane glycoprotein of malignant melanoma cells. "
06/11/1999 - "The cell surface glycoprotein MUC18MCAM/CD146 was originally defined as a marker of melanoma progression and has been suspected to be directly linked to the metastatic process of this malignancy. "
11/27/1997 - "MUC18/MCAM is a cell-surface glycoprotein that is strongly expressed on advanced human melanomas. "
09/01/1997 - "Mel-CAM was first identified as an integral membrane glycoprotein in human melanoma and is also abundantly expressed by endothelial cells of various origins. "
|4.||DNA (Deoxyribonucleic Acid)
|5.||Inosine Triphosphate (ITP)
|8.||Adenosine Triphosphate (ATP)
|10.||Lymphocyte Function-Associated Antigen-1 (LFA-1)
|1.||Renal Dialysis (Hemodialysis)
|2.||Drug Therapy (Chemotherapy)
|4.||Transplantation (Transplant Recipients)
|5.||Heterologous Transplantation (Xenotransplantation)